Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: web + 0.22  Related to the article below (Last Update: 8/4/2008)

Salix Pharmaceuticals Reports 2Q2008 Results
FOXBusiness -
Interested parties can access the conference call by way of web cast or telephone. The live web cast will be available at www.salix.com. A replay of the web ...SLXP

Earthtimes (press release)
athenahealth, Inc. Reports Second Quarter 2008 Results
WELT ONLINE, Germany -
A live webcast and replay will also be available shortly after the call is completed on the Company's investor web site: ...
Omnicare Reports Second Quarter Results Genetic Engineering News (press release)
Mothers Work Reports Third Quarter Fiscal 2008 Earnings Earthtimes (press release)
all 865 news articles »  OCR - MWRK - ATHN
Lydall Announces Financial Results for the Second Quarter and Six ...
CNNMoney.com -
The call may be accessed in a listen-only mode at 877-440-5804 and will be webcast live on the Company's web site www.lydall.com under the Investor ...LDL
Altra Holdings Announces Record Financial Results for the Second ...
MarketWatch -
Also, the company has posted slides on its web site at http://www.altramotion.com in the Investor Relations Section in the Events & Presentations tab to ...AIMC

RussiaToday
Watts Water Technologies Reports Second Quarter 2008 Results
WELT ONLINE, Germany - Jul 29, 2008
Watts Water Technologies, Inc. will hold a live web cast of its conference call to discuss second quarter results for 2008 on Tuesday, July 29, 2008, ...
GFI Group Inc. Announces Second Quarter 2008 Results; Declares ... MarketWatch
The Phoenix Companies, Inc. Second Quarter 2008 Earnings StreetInsider.com (subscription)
TTM Technologies, Inc. Reports Second Quarter 2008 Results Trading Markets (press release)
WELT ONLINE
all 1,219 news articles »  GFIG - UNM - PNX
K-Swiss Inc. Reports Second Quarter Results
MarketWatch - Jul 31, 2008
The Company will also provide an online Web simulcast and rebroadcast of this conference call. The live broadcast of K-Swiss' quarterly conference call will ...KSWS
Online Resources Posts Second Quarter 2008 Results
WELT ONLINE, Germany - Jul 29, 2008
Online Resources Corporation (Nasdaq:ORCC), a leading provider of web-based financial services, today reported financial and operating results for the three ...ORCC
Firefox 3 chipping away Safari market share, summer browsing ...
TG Daily - Aug 1, 2008
... of users were browsing the web using an iPhone. Following June 11, when the iPhone 3G was introduced, that share increased to 0.22% (recorded yesterday).
Tasty Baking Company Reports Second Quarter 2008 Results
MarketWatch - Aug 1, 2008
Investors will have the opportunity to listen to the call over the Internet at Tasty Baking Company's web site, http://www.tastykake.com. ...TSTY
digital newspapers
CNET News, CA - Jul 10, 2008
Kodak also claims a sub-0.22 second shot lag ("click to capture"). The Z1015 IS will ship in September for $349.95. As for the other model, the M1093 IS is ...
Source: Google News

[PS] WebSIFT: The Web Site Information Filter System -
R Cooley, PN Tan, J Srivastava - Proceedings of the Web Usage Analysis and User Profiling …, 1999 - cs.umn.edu
... from the University of Minnesota Department of Computer Science and Engineering
Web site; http ... The supports of these itemsets are 0.25% and 0.22% respectively. ...

Reliability of Web-based teledermatology consultations -
MO Oztas, E Calikoglu, K Baz, A Birol, M Onder, T … - Journal of Telemedicine and Telecare, 2004 - ingentaconnect.com
... 0.22?0.32). Seventy-seven per cent of the patients were correctly diagnosed by at
least two dermatologists when clinical information was provided. A Web- ...

Friends and neighbors on the Web -
LA Adamic, E Adar - Social Networks, 2003 - Elsevier
... For the Stanford social web C is 0.22 while for MIT it is 0.21, both 70 times greater
than for random graphs with the same number of nodes and edges. ...

Secretion capture and report web: use of affinity derivatized agarose microdroplets for the … -
F Gray, JS Kenney, JF Dunne - Journal of Immunological Methods, 1995 - Elsevier
... viable hybridoma cells using a secretion capture and reporter web (SCRW). ... brief boiling
in a microwave, filter-sterilized by passage through 0.22 pm disposable ...

Measuring the Independence of Central Banks and Its Effect on Policy Outcomes -
A Cukierman, SB Web, B Neyapti - The World Bank Economic Review, 1992 - World Bank
... Legal central bank in- depen- dence" (index) 0.33 0.33 0.31 0.30 0.30 0.30 0.29
0.29 0.27 0.27 0.27 0.27 0.25 0.24 0.24 0.22 0.21 0.21 0.21 0.20 0.20 0.18 0.17 ...

[PDF] Removal policies in network caches for world-wide web documents -
S Williams, M Abrams, CR Strandridge, G Abdulla, E … - Computer Communication Review, 1996 - cs.kent.edu
... caching in networks with workloads like ours could dramat- ically reduce the load
on popular Web servers. ... CGI 0.13 0.08 0.15 0.12 0.12 0.03 0.22 0.00 0.95 0.05 ...
-

Regulation of Lake Primary Productivity by Food Web Structure -
SR Carpenter, JF Kitchell, JR Hodgson, PA Cochran, … - Ecology, 1987 - JSTOR
... of these interannual differences in weather, as well as the dynamics of an undisturbed
food web. ... trap-1. h-1) 0 0 0 0 0.94 (0.22) 0 Bass (fish/ha) YOY --* 242 ...

Variation in d 15 N and d 13 C trophic fractionation: implications for aquatic food web studies -
MJ Vander Zanden, JB Rasmussen - Limnology and Oceanography, 2001 - JSTOR
... 0.22* 0.70 N= 15 8 13 5 Mean (+1 SE) 3.49 ... A literature review produced 35 A8'5N
estimates and 42 A^'3C estimates from 22 studies and 20 species (Web Appendix 1 ...

[PDF] IVOA Web Services Basic Profile Version 0.22 IVOA Working Draft 2005 September 30
A Schaaff - ivoa.net
... 5 7. Toward a VO Web Service Basic Profile.....5 ... 6 8.3
VO Support Interfaces 0.22 conformance [10 ...

[CITATION] Results 1-10 of about 30 for related: www. wpi. edu/Pubs/ETD/Avai...(0.22 seconds) An error occurred …
MP Firms, P Switching

Source: Google Scholar
 
 

Colorectal Cancer Patient's Immune Systems Stimulated To Fight Cancerous Cells By New Vaccine

Article Date: 21 Nov 2006 - 13:00pm (PST)
British researchers have developed a vaccine that stimulates colorectal cancer patients' immune systems to fight cancerous cells.

In a clinical trial of 67 patients, researchers at the University of Nottingham observed that when the vaccines were administered before and after surgery to remove cancerous tumors, they helped stimulated immune cell production in up to 70 percent of patients. These results are published in the November 15 issue of Clinical Cancer Research.

"This is the first vaccine shown to stimulate TNF-alpha - an immune-system protein that is very effective at killing cancer cells," said Lindy Durrant, senior author of the study and professor of cancer immunotherapy at the university.

The vaccine works by stimulating the patients' immune response to generate infection-fighting white blood cells called T cells, which in turn produce immune system proteins called cytokines that destroy cancer cells. The antibody contained in the vaccine, called 105AD7, was cloned from a patient who survived seven years with liver metastases from colorectal cancer, Durrant explained.

Article continues below and (thank you)
 
"This is very unusual as most patients die within one year of getting liver metastases," she said. "I thought if this antibody had helped this patient, if we could clone it, it might help others."

105AD7 is structurally similar to CD55, a protein that attaches to sugar molecules and is overexpressed in colorectal cancer cells, protecting them from attack by the body's immune system. While low levels of CD55 occur in all cells exposed to the immune system, increased expression of the protein has been observed in multiple types of tumors, including up to 80 percent of colorectal cancers.

During the trial -- the largest to date looking at 105AD7 plus surgery -- 67 patients with colorectal cancer who were scheduled for surgery to remove their primary tumor were randomly assigned to receive either 100 micrograms of 105AD7 with a powder to help absorb the vaccine, 105AD7 along with BCG (a bacteria used to stimulate the immune system in cancer patients) during the first immunization and the powder in subsequent vaccinations, or no treatment.

The patients, who had varying degrees of disease, averaged age 66. Twenty-eight patients had colon cancer while in 39 patients the primary tumor was located in the rectum.
 
Patients were immunized before surgery on the day they were recruited for the study, and again two weeks later if surgery had not yet been performed. The vaccines were continued three, six and 12 weeks after surgery, and then at three monthly intervals up to a maximum of 24 months after surgery. Blood samples were collected from the patients during recruitment, at surgery, and at the time of the three-, six- and 12-week post-operative immunizations. Additional blood samples were acquired one month after each subsequent immunization.

Laboratory tests of the blood samples indicated that a T-cell response against the vaccine was recorded in the majority of patients. The responses tended to have two peaks: one following the start of the immunization schedule and another several months later, after additional immunizations. About 70 percent of patients produced both TNF-alpha and GM-CSF - a protein that stimulates white blood cell production - in response to both the vaccine and to CD55.

"The immune responses to both the vaccine and CD55 were measurable, adding support to the use of CD55 as a target in cancer treatment," Durrant said.

Nineteen of the patients died during the follow-up period. Durrant and colleagues noted that the trial was not designed to study the effect of the vaccines on survival.

###

The research was supported by The Research Foundation Stiftelsen Onkologiska Klinikens i Uppsala Forskningsfond.

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes more than 24,000 basic, translational, and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 70 other countries. AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special Conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment, and patient care. AACR publishes five major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. Its most recent publication, CR, is a magazine for cancer survivors, patient advocates, their families, physicians, and scientists. It provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship, and advocacy.

Contact: Yarissa Ortiz
American Association for Cancer Research
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News9A ;